Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy
Clinical trial NCT03941262 · COMPLETED
Trial details
- NCT number
- NCT03941262
- Sponsor
- NKGen Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2023-02-17
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.